Avantor (NYSE:AVTR) Price Target Raised to $18.00

Avantor (NYSE:AVTR) had its price objective increased by Robert W. Baird from $17.00 to $18.00 in a research note published on Thursday morning, MarketBeat reports. Robert W. Baird currently has an outperform rating on the stock.

AVTR has been the topic of several other reports. Wolfe Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, July 30th. Royal Bank Of Canada increased their price objective on shares of Avantor from $14.00 to $17.00 and gave the company a “sector perform” rating in a research note on Wednesday. Citigroup lifted their target price on shares of Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Barclays boosted their target price on Avantor from $15.00 to $16.00 and gave the stock an “underweight” rating in a research note on Thursday. Finally, Wall Street Zen raised Avantor from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. Two investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Avantor has an average rating of “Hold” and an average target price of $14.77.

Avantor Price Performance

AVTR opened at $16.05 on Thursday. Avantor has a 1 year low of $7.26 and a 1 year high of $17.45. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.89 and a quick ratio of 1.18. The company has a market capitalization of $10.87 billion, a price-to-earnings ratio of 32.09, a P/E/G ratio of 9.04 and a beta of 0.94. The firm’s fifty day moving average price is $15.49 and its two-hundred day moving average price is $11.24.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, October 28th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.21 by $0.01. The company had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.64 billion. Avantor had a net margin of 5.08% and a return on equity of 9.79%. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.22 earnings per share. As a group, analysts anticipate that Avantor will post 0.82 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Avantor

Several large investors have recently modified their holdings of AVTR. GSA Capital Partners LLP bought a new stake in shares of Avantor in the second quarter valued at approximately $800,000. Oppenheimer Asset Management Inc. bought a new position in Avantor in the 2nd quarter worth approximately $805,000. Assenagon Asset Management S.A. boosted its holdings in Avantor by 425.0% in the 2nd quarter. Assenagon Asset Management S.A. now owns 556,871 shares of the company’s stock worth $5,513,000 after buying an additional 450,801 shares during the period. Freestone Grove Partners LP bought a new position in Avantor in the 2nd quarter worth approximately $56,577,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Avantor in the 2nd quarter worth approximately $1,922,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

About Avantor

Avantor, Inc is a global provider of mission-critical products and services used in the life sciences, healthcare, education, and advanced technology industries. The company supplies chemicals, reagents, laboratory consumables, equipment, and other materials used in research, development, manufacturing, and quality-control activities.

Avantor also provides specialized solutions for biopharmaceutical production, including materials and services that support drug development, biologics manufacturing, and other bioprocessing applications.